Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1
Thomas J. Ow(Montefiore Medical Center), Evripidis Gavathiotis(Albert Einstein College of Medicine)
Cited by 35
Related Papers
Inhibitors of BRAF dimers using an allosteric site
|Nature Communications|2020|82
Eltrombopag directly inhibits BAX and prevents cell death
|Nature Communications|2021|71